Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Feb 13, 2025
Date Accepted: Aug 11, 2025

The final, peer-reviewed published version of this preprint can be found here:

Monitoring People With COVID-19 at Home With the COVIDFree@Home Program: Feasibility Cohort Study

Gershon AS, Mariakakis A, de Lara E, Munn J, Calligan M, Liaqat D, Liaqat S, Chen J, To T, Lam PW, Simor A, Chan AK, Andany N, Masood S, Daneman N, Chan T, Graham C, Comondore V, de Moulliac A, Tu AY, Wu R

Monitoring People With COVID-19 at Home With the COVIDFree@Home Program: Feasibility Cohort Study

JMIR Form Res 2025;9:e69140

DOI: 10.2196/69140

PMID: 41061108

PMCID: 12507130

Monitoring People with COVID-19 at Home with the COVIDFree@Home Program: a Feasibility Cohort Study

  • Andrea S. Gershon; 
  • Alex Mariakakis; 
  • Eyal de Lara; 
  • Joseph Munn; 
  • Maryann Calligan; 
  • Daniyal Liaqat; 
  • Salaar Liaqat; 
  • Junlin Chen; 
  • Teresa To; 
  • Philip W. Lam; 
  • Andrew Simor; 
  • Adrienne K. Chan; 
  • Nisha Andany; 
  • Sameer Masood; 
  • Nick Daneman; 
  • Tiffany Chan; 
  • Christopher Graham; 
  • Vikram Comondore; 
  • Andre de Moulliac; 
  • Alice Y. Tu; 
  • Robert Wu

ABSTRACT

Background:

During the COVID-19 pandemic, many with acute infection isolated at home, with a small but significant number requiring hospitalization. Patients were afraid and clinicians uncertain. We developed the COVIDFree@home smartphone app to monitor and support people. It was uncertain if such an app would be used by patients is and how this might support patient care.

Objective:

To determine the feasibility of using a smartphone app and clinician dashboard for remote clinical monitoring of people with COVID-19 at home.

Methods:

A feasibility study set at three hospital sites (University Health Network, Sunnybrook Health Sciences Centre, and Trillium Health Partners) between 2020 and 2022 was conducted. Participants newly diagnosed with COVID-19 were asked to use a smartphone app called COVIDFree@home daily for 10 days while isolating at home. Their data—including symptoms, temperature, and oxygen saturation—were monitored on a clinician-facing dashboard. The primary outcome of feasibility was the number of patients who used the app. We also examined patient satisfaction.

Results:

We recruited 431 patients as study participants, of whom 376 (87.2%) used the app to report symptoms or oxygen saturation at least once. Participants reported symptoms an average of 1.7 times per day (standard deviation = 1.1 days) with 92% reporting them for at least 6 days. There were 19 hospitalizations (4.4%) among study participants.

Conclusions:

Patients with acute COVID-19 infection engaged with a remote home monitoring platform. While COVID-19 no longer evokes the same level of fear as it did during the pandemic, millions are hospitalized and die from acute respiratory infections each year. Remote monitoring has the potential to help improve health outcomes for such infections and reduce strain on the healthcare system during future pandemics. Clinical Trial: Clinicaltrials.Gov: NCT04453774


 Citation

Please cite as:

Gershon AS, Mariakakis A, de Lara E, Munn J, Calligan M, Liaqat D, Liaqat S, Chen J, To T, Lam PW, Simor A, Chan AK, Andany N, Masood S, Daneman N, Chan T, Graham C, Comondore V, de Moulliac A, Tu AY, Wu R

Monitoring People With COVID-19 at Home With the COVIDFree@Home Program: Feasibility Cohort Study

JMIR Form Res 2025;9:e69140

DOI: 10.2196/69140

PMID: 41061108

PMCID: 12507130

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.